11:24 AM
 | 
Jan 02, 2018
 |  BC Extra  |  Financial News

Cue spikes after pricing $66.2M IPO

Cancer and autoimmune company Cue Biopharma Inc. (NASDAQ:CUE) climbed $4.13 (55%) to $11.63 in its first day of trading Tuesday after raising $66.2 million through the sale of 8.8 million shares at $7.50 in an IPO underwritten by MDB...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >